Halozyme Therapeutics Statistics

Total Valuation

LON:0J2O has a market cap or net worth of GBP 5.63 billion. The enterprise value is 6.37 billion.

Market Cap	5.63B
Enterprise Value	6.37B

Important Dates

The last earnings date was Thursday, February 20, 2025.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-3.56%
Shares Change (QoQ)	-0.89%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	121.75M

Valuation Ratios

The trailing PE ratio is 15.86.

PE Ratio	15.86
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.72, with an EV/FCF ratio of 17.03.

EV / Earnings	17.96
EV / Sales	7.93
EV / EBITDA	12.72
EV / EBIT	14.60
EV / FCF	17.03

Financial Position

The company has a current ratio of 7.80, with a Debt / Equity ratio of 4.22.

Current Ratio	7.80
Quick Ratio	6.50
Debt / Equity	4.22
Debt / EBITDA	2.43
Debt / FCF	3.28
Interest Coverage	30.48

Financial Efficiency

Return on equity (ROE) is 198.42% and return on invested capital (ROIC) is 19.61%.

Return on Equity (ROE)	198.42%
Return on Assets (ROA)	18.16%
Return on Invested Capital (ROIC)	19.61%
Return on Capital Employed (ROCE)	28.66%
Revenue Per Employee	2.32M
Profits Per Employee	1.01M
Employee Count	373
Asset Turnover	0.53
Inventory Turnover	1.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +60.90% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+60.90%
50-Day Moving Average	53.11
200-Day Moving Average	53.12
Relative Strength Index (RSI)	59.81
Average Volume (20 Days)	1,064

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.82

Income Statement

In the last 12 months, LON:0J2O had revenue of GBP 811.01 million and earned 354.73 million in profits. Earnings per share was 2.74.

Revenue	811.01M
Gross Profit	620.53M
Operating Income	440.50M
Pretax Income	445.02M
Net Income	354.73M
EBITDA	498.90M
EBIT	440.50M
Earnings Per Share (EPS)	2.74

Full Income Statement

Balance Sheet

The company has 476.13 million in cash and 1.23 billion in debt, giving a net cash position of -751.19 million.

Cash & Cash Equivalents	476.13M
Total Debt	1.23B
Net Cash	-751.19M
Net Cash Per Share	n/a
Equity (Book Value)	290.61M
Book Value Per Share	2.36
Working Capital	755.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 382.66 million and capital expenditures -8.54 million, giving a free cash flow of 374.12 million.

Operating Cash Flow	382.66M
Capital Expenditures	-8.54M
Free Cash Flow	374.12M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 76.51%, with operating and profit margins of 54.32% and 43.74%.

Gross Margin	76.51%
Operating Margin	54.32%
Pretax Margin	54.87%
Profit Margin	43.74%
EBITDA Margin	61.52%
EBIT Margin	54.32%
FCF Margin	46.13%

Dividends & Yields

LON:0J2O does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.56%
Shareholder Yield	3.56%
Earnings Yield	6.31%
FCF Yield	6.65%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0J2O has an Altman Z-Score of 4.31.

Altman Z-Score	4.31
Piotroski F-Score	n/a